Cornerstone has agreed with Chiesi that it would present these proposa...King and Pain Therapeutics Announce REMOXY(R) NDA Update...S&P 500 Index company, seeks to capitalize on opportunities in the pharmaceutical industry through the development, including through in-licensing arrangements and acquisitions, of novel branded prescription pharmaceutical products that complement the Company's focus